Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary Markets February 12, 2024 [ad_1] Trxade Well being, Inc. (NASDAQ: MEDS) operates as an built-in drug procurement and supply platform, centered on digitalizing the…
Earnings: Trxade Health (MEDS) reports 16% rise in FY22 revenue; loss narrows Markets March 27, 2023 [ad_1] Trxade Well being Inc (NASDAQ: MEDS), a number one well being service IT firm, reported a double-digit enhance in…
